Interleukin‑35 reduces inflammation in acute lung injury through inhibiting TLR4/NF‑κB signaling pathways

Pan,Wei; Xu,Xiaoheng; Wang,Yan; Song,Xingyu

doi:10.3892/etm.2020.8407

Interleukin‑35 reduces inflammation in acute lung injury through inhibiting TLR4/NF‑κB signaling pathways

Authors:
- Wei Pan
- Xiaoheng Xu
- Yan Wang
- Xingyu Song
View Affiliations

Affiliations: Department of Pediatrics, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China, Experimental Center, Jilin Police College, Changchun, Jilin 130117, P.R. China
Published online on: January 2, 2020 https://doi.org/10.3892/etm.2020.8407
Pages: 1695-1700
Copyright: © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acute lung injury (ALI) in children is a complex disease that is accompanied by an inflammatory response. The pathogenesis of ALI in children is not yet well understood. Mice with ALI exhibit inflammation of the lungs and decreased expression of interleukin (IL)‑35. To investigate whether the function of IL‑35 affects lipopolysaccharide (LPS)‑induced ALI, IL‑35 was overexpressed in cells. Enzyme‑linked immunosorbent assays indicated decreased levels of IL‑6 and tumor necrosis factor‑α in LPS‑induced and agomir‑IL‑35‑treated murine RAW264.7 macrophages. Finally, toll‑like receptor 4 (TLR4)/NF‑κB signaling pathways were analyzed. The expression of TLR4, NF‑κB p65 and NF‑κB p50 were decreased, as was the degradation of NF‑κB inhibitor‑α, in LPS‑induced and agomir‑IL‑35‑treated murine RAW264.7 macrophages. The results of the present study demonstrated that IL‑35 may exhibit a protective role in ALI by modulating the TLR4/NF‑κB signaling pathways.

View Figures

View References

1	Dong ZW and Yuan YF: Juglanin suppresses fibrosis and inflammation response caused by LPS in acute lung injury. Int J Mol Med. 41:3353–3365. 2018.PubMed/NCBI
2	Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, et al: Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 30:51–61. 2004. View Article : Google Scholar : PubMed/NCBI
3	Gilliland FD, McConnell R, Peters J and Gong H Jr: A theoretical basis for investigating ambient air pollution and children's respiratory health. Environ Health Perspect. 3:403–407. 1999. View Article : Google Scholar
4	Tang L, Zhang H, Wang C, Li H, Zhang Q and Bai J: M2A and M2C macrophage subsets ameliorate inflammation and fibroproliferation in acute lung injury through interleukin 10 pathway. Shock. 48:119–129. 2017. View Article : Google Scholar : PubMed/NCBI
5	McArdle MA, Finucane OM, Connaughton RM, McMorrow AM and Roche HM: Mechanisms of obesity-induced inflammation and insulin resistance: Insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 4:522013. View Article : Google Scholar : PubMed/NCBI
6	Dai JP, Wang QW, Su Y, Gu LM, Zhao Y, Chen XX, Chen C, Li WZ, Wang GF and Li KS: Emodin inhibition of influenza A virus replication and influenza viral pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB pathways. Molecules. 22:E17542017. View Article : Google Scholar : PubMed/NCBI
7	Wu J, Li L, Sun Y, Huang S, Tang J, Yu P and Wang G: Altered molecular expression of the TLR4/NF-κB signaling pathway in mammary tissue of Chinese Holstein cattle with mastitis. PLoS One. 10:e01184582015. View Article : Google Scholar : PubMed/NCBI
8	Yang J, Yang J, Ding JW, Chen LH, Wang YL, Li S and Wu H: Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury. Inflammation. 31:304–312. 2008. View Article : Google Scholar : PubMed/NCBI
9	Jiang S, Shan F, Zhang Y, Jiang L and Cheng Z: Increased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD. Int J Chron Obstruct Pulmon Dis. 13:2483–2494. 2018. View Article : Google Scholar : PubMed/NCBI
10	Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U, et al: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol. 147:874–882. 1991.PubMed/NCBI
11	Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, Gutchigian S, Frisch A, Hodge I, Jiang X, et al: IL-35 is a novel responsive anti-inflammatory cytokine-a new system of categorizing anti-inflammatory cytokines. PLoS One. 7:e336282012. View Article : Google Scholar : PubMed/NCBI
12	Wang W, Li P and Yang J: Decreased circulating interleukin-35 levels are related to interleukin-4-producing CD8+ Tcells in patients with allergic asthma. Iran J Allergy Asthma Immunol. 14:379–385. 2015.PubMed/NCBI
13	Li Y, Pan X, Peng X, Li S, Zhou Y, Zheng X and Li M: Adenovirus-mediated interleukin-35 gene transfer suppresses allergic airway inflammation in a murine model of asthma. Inflamm Res. 64:767–774. 2015. View Article : Google Scholar : PubMed/NCBI
14	Wu Q, Li R, Soromou LW, Chen N, Yuan X, Sun G, Li B and Feng H: p-Synephrine suppresses lipopolysaccharide-induced acute lung injury by inhibition of the NF-κB signaling pathway. Inflamm Res. 63:429–439. 2014. View Article : Google Scholar : PubMed/NCBI
15	Thomas NJ, Jouvet P and Willson D: Acute lung injury in children-kids really aren't just ‘little adults’. Pediatr Crit Care Med. 14:429–432. 2013. View Article : Google Scholar : PubMed/NCBI
16	Jiang Z, Chen Z, Li L, Zhou W and Zhu L: Lack of SOCS3 increases LPS-induced murine acute lung injury through modulation of Ly6C (+) macrophages? Respir Res. 18:2172017. View Article : Google Scholar : PubMed/NCBI
17	Egwuagu CE, Yu CR, Sun L and Wang R: Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases. Cytokine Growth Factor Rev. 26:587–93. 2015. View Article : Google Scholar : PubMed/NCBI
18	Pan X, Xu K and Li Y, Wang X, Peng X, Li M and Li Y: Interleukin-35 expression protects against cigarette smoke-induced lung inflammation in mice. Biomed Pharmacother. 110:727–732. 2019. View Article : Google Scholar : PubMed/NCBI
19	Akira S and Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar : PubMed/NCBI
20	Qi W, Yang X, Ye N, Li S, Han Q, Huang J and Wu B: TLR4 gene in the regulation of periodontitis and its molecular mechanism. Exp Ther Med. 18:1961–1966. 2019.PubMed/NCBI
21	Zhu C, Bao NR, Chen S and Zhao JN: HBD-3 regulation of the immune response and the LPS/TLR4-mediated signaling pathway. Exp Ther Med. 12:2150–2154. 2016. View Article : Google Scholar : PubMed/NCBI
22	Sun W, Gao Y, Yu X, Yuan Y, Yi J, Zhang Z, Cheng Y, Li Y, Peng X and Cha X: ‘Psoriasis 1’ reduces psoriasis-like skin inflammation by inhibiting the VDR-mediated nuclear NF-κB and STAT signaling pathways. Mol Med Rep. 18:2733–2743. 2018.PubMed/NCBI
23	Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC and Zinman B; EMPA-REG OUTCOME Investigators, : Empagliflozin and progression of kidney disease in Type 2 diabetes. N Engl J Med. 375:323–334. 2016. View Article : Google Scholar : PubMed/NCBI